TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21371993

Group type: EXPERIMENTAL
Intervention: Web-based pharmacist care (e-BP)
Number of subjects: 9298

Group type: COMPARATOR
Intervention: Lack of computer access
Number of subjects: 9298

Group type: COMPARATOR
Intervention: Willingness to participate in the intervention
Number of subjects: 9298

Group type: EXPERIMENTAL
Intervention: Risk factors for uncontrolled BP among participants with computer access
Number of subjects: 9298
Study: 19393087

Group type: EXPERIMENTAL
Intervention: iFOBt with a faeces collection paper
Number of subjects: 10000

Group type: COMPARATOR
Intervention: iFOBt without a collection paper
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: iFOBt (both groups)
Number of subjects: 10000
Study: 18694250

Group type: EXPERIMENTAL
Intervention: BostonBreathes (BB) system - an interactive website for patient education, monitoring, and clinical teamwork.
Number of subjects: 0
Study: 15126974

Group type: EXPERIMENTAL
Intervention: Alginate with film dressing
Number of subjects: 40

Group type: COMPARATOR
Intervention: Paraffin gauze
Number of subjects: 40

Group type: COMPARATOR
Intervention: Alginate alone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Film alone
Number of subjects: 40
Study: 11228204

Group type: EXPERIMENTAL
Intervention: Oocytes cryopreserved with cumuli partially removed mechanically
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oocytes cryopreserved with cumuli totally removed enzymatically
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oocytes cryopreserved with sucrose concentration of 0.2 mol/l
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oocytes cryopreserved with sucrose concentration of 0.3 mol/l
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oocytes with longer exposure time to cryoprotectants (15 min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI) of thawed oocytes
Number of subjects: 0
Study: 9492971

Group type: EXPERIMENTAL
Intervention: Periodic blood transfusions to reduce sickle hemoglobin to 30% or less
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 120
Study: 9895043

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg t.i.d. for 3 days
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo for 3 days
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 2527376

Group type: EXPERIMENTAL
Intervention: Clonazepam (n = 13)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Alprazolam (n = 8)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (n = 3)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Male patients
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Panic disorder patients (n = 24)
Number of subjects: 24
Study: 12915

Group type: EXPERIMENTAL
Intervention: Fluphenazine with nortriptyline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 0
Study: 31567027

Group type: EXPERIMENTAL
Intervention: Forward-Facing Child Restraint System (FFCRS)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Belt-Positioning Booster Seat (BS)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Correctly restrained children
Number of subjects: 72

Group type: COMPARATOR
Intervention: Incorrectly restrained children
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Overall child occupant behavior
Number of subjects: 72
Study: 28843988

Group type: EXPERIMENTAL
Intervention: Amagugu intervention
Number of subjects: 464

Group type: COMPARATOR
Intervention: Enhanced standard of care
Number of subjects: 464
Study: 26038524

Group type: EXPERIMENTAL
Intervention: Evidence-based medications after acute myocardial infarction
Number of subjects: 7425

Group type: EXPERIMENTAL
Intervention: Follow-up appointments made before discharge
Number of subjects: 7425

Group type: EXPERIMENTAL
Intervention: Provider explained potential side effects of medications
Number of subjects: 7425

Group type: EXPERIMENTAL
Intervention: Lower medication adherence
Number of subjects: 7425
Study: 23625188

Group type: EXPERIMENTAL
Intervention: Ketoconazole 400 mg/day with 100 mg mirabegron OCAS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rifampicin 600 mg/day with 100 mg mirabegron OCAS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mirabegron 160 mg immediate release in poor metabolizers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 and 100 mg OCAS in different CYP2D6 phenotypes
Number of subjects: 0
Study: 21802745

Group type: EXPERIMENTAL
Intervention: Micronutrient group (N=16)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (N=17)
Number of subjects: 33
Study: 19824412

Group type: EXPERIMENTAL
Intervention: Recruitment Maneuver (RM) group (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional ventilation (Control group, n=10)
Number of subjects: 20
Study: 17112810

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole plus 20 mg famotidine (full-concomitant regimen)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole alone
Number of subjects: 15

Group type: COMPARATOR
Intervention: 20 mg famotidine alone
Number of subjects: 15
Study: 15701218

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.4% ophthalmic solution
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 11298850

Group type: EXPERIMENTAL
Intervention: Special intervention programme including dietary recommendations, weight loss instructions, self-monitoring of blood glucose for diabetics, smoking cessation programme, and follow-up visits every 6 months.
Number of subjects: 164

Group type: COMPARATOR
Intervention: Usual care group with advice to quit smoking and lower fat and glucose consumption, similar antihypertensive treatment as intervention group.
Number of subjects: 164
Study: 9290464

Group type: EXPERIMENTAL
Intervention: Thyrotropin-releasing hormone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8100627

Group type: EXPERIMENTAL
Intervention: Nifedipine-ibopamine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Diltiazem-ibopamine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Calcium channel blocker plus placebo
Number of subjects: 8
Study: 3535100

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both metoclopramide and cimetidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 29773463

Group type: EXPERIMENTAL
Intervention: Alarm system treatment for 16 weeks (Group B)
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Alarm system treatment for 20 weeks (Group C)
Number of subjects: 455

Group type: COMPARATOR
Intervention: Alarm system treatment for 12 weeks (Group A)
Number of subjects: 455
Study: 27777127

Group type: EXPERIMENTAL
Intervention: Electronic Medication Complete Communication (EMC2) Strategy
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1200
Study: 24434748

Group type: EXPERIMENTAL
Intervention: Fluorine-synthetic fiber socks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Cotton socks
Number of subjects: 17
Study: 22834123

Group type: EXPERIMENTAL
Intervention: Polychemotherapy with cycloferon (111 patients)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Polychemotherapy only (95 patients)
Number of subjects: 238
Study: 19476474

Group type: EXPERIMENTAL
Intervention: linagliptin 2.5 mg
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: linagliptin 10 mg
Number of subjects: 47

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: linagliptin
Number of subjects: 47
Study: 17590219

Group type: EXPERIMENTAL
Intervention: HAMD-7 depression metric
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison to tertiary sample
Number of subjects: 0
Study: 15045033

Group type: EXPERIMENTAL
Intervention: (90)Y-ibritumomab tiuxetan (0.4 mCi/kg)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: (90)Y-ibritumomab tiuxetan (0.3 mCi/kg)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 227
Study: 11472705

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg)
Number of subjects: 3916

Group type: COMPARATOR
Intervention: Simvastatin (10 mg)
Number of subjects: 3916

Group type: COMPARATOR
Intervention: Lovastatin (20 mg)
Number of subjects: 3916

Group type: COMPARATOR
Intervention: Fluvastatin (20 mg)
Number of subjects: 3916

Group type: COMPARATOR
Intervention: Pravastatin (10 mg)
Number of subjects: 3916
Study: 9926538

Group type: EXPERIMENTAL
Intervention: Twelve Step Facilitation Therapy (TSF)
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Alcoholics Anonymous (AA) involvement
Number of subjects: 806

Group type: COMPARATOR
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 806

Group type: COMPARATOR
Intervention: Cognitive Behavioral Coping Skills Therapy (CBT)
Number of subjects: 806
Study: 7831650

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) - enoxaparin 4000 anti-Xa units once a day subcutaneously for 3 months
Number of subjects: 187

Group type: COMPARATOR
Intervention: Warfarin treatment for 3 months
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: LMWH (enoxaparin) during 9-month follow-up
Number of subjects: 187

Group type: COMPARATOR
Intervention: Warfarin during 9-month follow-up
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: LMWH after one year
Number of subjects: 187

Group type: COMPARATOR
Intervention: Warfarin after one year
Number of subjects: 187
Study: 2978782

Group type: EXPERIMENTAL
Intervention: University of Mississippi dental care system (automatic toothbrushing device)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine (ordinary, manual) regimens of oral hygiene
Number of subjects: 0
Study: 7007588

Group type: EXPERIMENTAL
Intervention: High-dose steroid regimen
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Low-dose steroid regimen
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Antacids alone
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Antacids supplemented with cimetidine
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Mini-dose heparin
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Full-dose heparin
Number of subjects: 131
Study: 28810394

Group type: EXPERIMENTAL
Intervention: Face-to-face behavioral weight loss
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Web-based behavioral weight loss
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Hybrid (web plus optional community sessions)
Number of subjects: 52
Study: 28683763

Group type: EXPERIMENTAL
Intervention: PSN
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 14

Group type: COMPARATOR
Intervention: PSP
Number of subjects: 14
Study: 26514759

Group type: EXPERIMENTAL
Intervention: Pulmonary arterial hypertension patients
Number of subjects: 65

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 65
Study: 22404253

Group type: EXPERIMENTAL
Intervention: Rubber dam
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (cotton rolls)
Number of subjects: 72
Study: 23024440

Group type: EXPERIMENTAL
Intervention: Dexamethasone 2 × 8 mg/d (dex-early)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Dexamethasone started on day 2 at 4,559 m (dex-late)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 21
Study: 19123142

Group type: EXPERIMENTAL
Intervention: Levofloxacin 0.5% eyedrops three times daily for 5 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Classic dosage group (every 2 hours on days 1 and 2, then every 4 hours on days 3-5)
Number of subjects: 120
Study: 17447828

Group type: EXPERIMENTAL
Intervention: Modafinil 200 mg/day during week 1, 300 mg/day during week 2, then 200, 300 or 400 mg/day based on efficacy and tolerability assessment.
Number of subjects: 266
Study: 15044817

Group type: EXPERIMENTAL
Intervention: PMMA‐CHDF (polymethylmethacrylate membrane hemofilter)
Number of subjects: 25
Study: 11813282

Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 821

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 821
Study: 9701178

Group type: EXPERIMENTAL
Intervention: Fish-oil-enriched sunflower oil (FO) margarine
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sunflower oil (SO) margarine
Number of subjects: 47
Study: 7904002

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 302

Group type: COMPARATOR
Intervention: Minilaparotomy cholecystectomy
Number of subjects: 302
Study: 2545054

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (1500 aPTT U) combined with 0.5 mg dihydroergotamine (LMH/DHE)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Standard heparin (2500 IU) combined with 0.5 mg dihydroergotamine (H/DHE)
Number of subjects: 201
Study: 790113

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate by inhalation (400 mug/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Prednisolone by mouth
Number of subjects: 14
Study: 31270121

Group type: EXPERIMENTAL
Intervention: DentalVibe (DV) device
Number of subjects: 41
Study: 28327450

Group type: EXPERIMENTAL
Intervention: ASP (attenuated-signal plaque) observed pre-intervention
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: ASP score pre-intervention
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: ASP score during follow-up
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: CP (calcified plaque) score during follow-up
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: ASP score decrease
Number of subjects: 136
Study: 26267141

Group type: EXPERIMENTAL
Intervention: Integrated Community Case Management (iCCM)
Number of subjects: 1036

Group type: COMPARATOR
Intervention: Control (no iCCM)
Number of subjects: 1036
Study: 22871378

Group type: EXPERIMENTAL
Intervention: Greening intervention (cleaning, planting grass and trees, building a wooden fence)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 29
Study: 21913053

Group type: EXPERIMENTAL
Intervention: Atazanavir (300/100 mg once daily)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Atazanavir
Number of subjects: 82
Study: 20037643

Group type: EXPERIMENTAL
Intervention: ITN use
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Older age (42-80 months)
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Interaction of ITN use and older age
Number of subjects: 383
Study: 18172382

Group type: EXPERIMENTAL
Intervention: Web-based intervention in Nanhua county (computers, training, ongoing support)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Web-based intervention in Mouding county (computers only)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group in Dayao county (no intervention)
Number of subjects: 0
Study: 14743040

Group type: EXPERIMENTAL
Intervention: Zidovudine (9 pairs)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Didanosine (12 pairs)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combined therapy (5 pairs)
Number of subjects: 26
Study: 11502515

Group type: EXPERIMENTAL
Intervention: Continuous infusion of vancomycin (CIV)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Intermittent infusions of vancomycin (IIV)
Number of subjects: 119
Study: 9509950

Group type: EXPERIMENTAL
Intervention: 75 mg of aspirin (ASA)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 250
Study: 7512101

Group type: EXPERIMENTAL
Intervention: 60 mg of terfenadine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2975583

Group type: EXPERIMENTAL
Intervention: Depotmedroxyprogesterone acetate (Depoprovera) 150 mg every 84 +/- 7 days
Number of subjects: 400

Group type: COMPARATOR
Intervention: Norethisterone enanthate (Noristerat) 200 mg every 56 +/- 7 days
Number of subjects: 400
Study: 31174831

Group type: EXPERIMENTAL
Intervention: Candidate 1 (S2/cre5/S15domV/rec1/hifi3)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Candidate 2 (S2/S15domV/CpG40)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Candidate 1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Candidate 2
Number of subjects: 30
Study: 29037984

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (administered every 3-4 weeks for six doses, then every 3-6 months until the end of 5 years)
Number of subjects: 1739

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 1739

Group type: COMPARATOR
Intervention: Control treatment (standard adjuvant systemic therapy alone)
Number of subjects: 1739
Study: 25149298

Group type: EXPERIMENTAL
Intervention: Robotic guidance (group 2)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Manual guidance (group 1)
Number of subjects: 70
Study: 23515640

Group type: EXPERIMENTAL
Intervention: Community health worker (CHW) intervention
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study: 21247520

Group type: EXPERIMENTAL
Intervention: Fenofibric acid plus low-dose statin
Number of subjects: 1393

Group type: EXPERIMENTAL
Intervention: Fenofibric acid plus moderate-dose statin
Number of subjects: 1393

Group type: COMPARATOR
Intervention: Low-dose statin monotherapy
Number of subjects: 1393

Group type: COMPARATOR
Intervention: Moderate-dose statin monotherapy
Number of subjects: 1393

Group type: COMPARATOR
Intervention: High-dose statin monotherapy
Number of subjects: 1393

Group type: EXPERIMENTAL
Intervention: Low-dose combination treatment
Number of subjects: 1393

Group type: EXPERIMENTAL
Intervention: Moderate-dose combination treatment
Number of subjects: 1393

Group type: COMPARATOR
Intervention: Corresponding-dose statins
Number of subjects: 1393
Study: 18423042

Group type: EXPERIMENTAL
Intervention: Hydrodilatation with corticosteroids
Number of subjects: 76

Group type: COMPARATOR
Intervention: Corticosteroids alone
Number of subjects: 76
Study: 17495988

Group type: EXPERIMENTAL
Intervention: Immediate cognitive therapy for 12 weeks (mean of 5.9 sessions during 12 weeks and 2.0 sessions thereafter)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Immediate cognitive therapy for 12 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 58
Study: 12920367

Group type: EXPERIMENTAL
Intervention: Daivobet (calcipotriol 50 micro g/g, betamethasone dipropionate 0.5 mg/g)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Diproson (betamethasone dipropionate 0.05 mg/g)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Daivobet and its vehicle
Number of subjects: 45

Group type: COMPARATOR
Intervention: Diproson and its vehicle
Number of subjects: 45
Study: 10618556

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate
Number of subjects: 10400

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 10400
Study: 9373470

Group type: EXPERIMENTAL
Intervention: Argon laser retinopexy (2 rows of 360 degrees) applied 3-6 weeks prior to silicone oil removal
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (removal of silicone oil without argon laser retinopexy)
Number of subjects: 31
Study: 8376687

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 2569

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2569
Study: 3519092

Group type: EXPERIMENTAL
Intervention: 400 mg acebutolol once daily for 12 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29428986

Group type: EXPERIMENTAL
Intervention: Health Literacy and ESL Curriculum with CVD specific content
Number of subjects: 155

Group type: COMPARATOR
Intervention: Conventional ESL curriculum
Number of subjects: 155
Study: 25700181

Group type: EXPERIMENTAL
Intervention: Nasogastric tube feeding
Number of subjects: 35

Group type: COMPARATOR
Intervention: Nil-by-mouth
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study: 24591821

Group type: EXPERIMENTAL
Intervention: Progressive resistance and balance training under the guidance of a physiotherapist for 6 months, then facility-guided maintenance training for 6 months
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study: 22717195

Group type: EXPERIMENTAL
Intervention: Unplugged intervention
Number of subjects: 1874

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1874
Study: 20639724

Group type: EXPERIMENTAL
Intervention: Stronger group (n = 8) trained with maximal-effort jump squats with 0%-30% 1RM, three times per week for 10 weeks.
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Weaker group (n = 8) trained with maximal-effort jump squats with 0%-30% 1RM, three times per week for 10 weeks.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (n = 8) with no training intervention.
Number of subjects: 24
Study: 18391850

Group type: EXPERIMENTAL
Intervention: Listening to music designed to increase vitality and improve heart rate variability (HRV) for 20 minutes
Number of subjects: 47

Group type: COMPARATOR
Intervention: Resting for 20 minutes
Number of subjects: 47
Study: 15822738

Group type: EXPERIMENTAL
Intervention: Dysport (botulinic toxin type A)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Amithryptiline (50 mg/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Amithryptiline (reduced dosage) combined with Dysport
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 10
Study: 12032787

Group type: EXPERIMENTAL
Intervention: 4 mg/kg every 24 hours (once-daily regimen)
Number of subjects: 41

Group type: COMPARATOR
Intervention: 2.5 mg/kg every 12 hours (twice-daily regimen)
Number of subjects: 41
Study: 10354195

Group type: EXPERIMENTAL
Intervention: Moderate red wine consumption (50 g per day of alcohol)
Number of subjects: 5

Group type: COMPARATOR
Intervention: No alcohol consumption (control)
Number of subjects: 5
Study: 8933894

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (NS) 4 mg administered via inhalation chamber 30 minutes prior to exercise
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (NS) 4 mg every 8 hours during four weeks plus 4 mg of NS 30 minutes before exercise
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg prior to exercise)
Number of subjects: 13